PharmGKB summary: isoniazid pathway, pharmacokinetics

被引：42

作者：

Klein, Daniel J. ^{[1
,3
]}

Boukouvala, Sotiria ^{[4
]}

McDonagh, Ellen M. ^{[1
]}

Shuldiner, Scott R. ^{[1
]}

Laurieri, Nicola ^{[5
]}

Thorn, Caroline F. ^{[1
]}

Altman, Russ B. ^{[1
,2
]}

Klein, Teri E. ^{[1
]}

机构：

[1] Stanford Univ, Dept Genet, Stanford, CA 94305 USA

[2] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA

[3] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA

[4] Democritus Univ Thrace, Dept Mol Biol & Genet, Alexandroupolis, Greece

[5] Univ Oxford, Dept Pharmacol, Oxford, England

来源：

PHARMACOGENETICS AND GENOMICS | 2016年 / 26卷 / 09期

关键词：

anti-tuberculosis drug-induced hepatotoxicity; cytochrome P450 2E1; GSTT1; GSTM1; isoniazid; N-acetyltransferase; 2; pharmacokinetics; DRUG-INDUCED HEPATOTOXICITY; INDUCED LIVER-INJURY; N-ACETYLTRANSFERASE; S-TRANSFERASE M1; CYTOCHROME-P450; 2E1; GENOTYPE; GSTT1 GENETIC POLYMORPHISMS; SUSCEPTIBILITY RISK-FACTOR; HEPATIC BILE-ACIDS; ANTITUBERCULOSIS DRUGS; TUBERCULOSIS PATIENTS;

D O I：

10.1097/FPC.0000000000000232

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

[No abstract available]

引用

页码：436 / 444

页数：9

共 114 条

[21] Pharmacogenomics of adverse drug reactions [J].

Daly, Ann K. .

GENOME MEDICINE, 2013, 5

[22] Genetic association studies in drug-induced liver injury [J].

Daly, Ann K. ;

Day, Christopher P. .

DRUG METABOLISM REVIEWS, 2012, 44 (01) :116-126

[23]

Daly AK, 2010, PHARMACOGENOMICS, V11, P607, DOI [10.2217/pgs.10.24, 10.2217/PGS.10.24]

[24]

Teixeira RLD, 2011, MEM I OSWALDO CRUZ, V106, P716

[25] DETERMINATION OF ISONIAZID AND ITS METABOLITES ACETYLISONIAZID, MONOACETYLHYDRAZINE, DIACETYLHYDRAZINE, ISONICOTINIC ACID AND ISONICOTINYLGLYCINE IN SERUM AND URINE [J].

ELLARD, GA ;

WALLACE, SM ;

GAMMON, PT .

BIOCHEMICAL JOURNAL, 1972, 126 (03) :449-&

[26] PHARMACOKINETICS OF ISONIAZID METABOLISM IN MAN [J].

ELLARD, GA ;

GAMMON, PT .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1976, 4 (02) :83-113

[27] Anti-infectives - Adverse reactions to first-line antituberculosis drugs [J].

Forget, Eric J. ;

Menzies, Dick .

EXPERT OPINION ON DRUG SAFETY, 2006, 5 (02) :231-249

[28] Effects of N-acetyltransferase 2 (NAT2), CYP2E1 and Glutathione-S-transferase (GST) genotypes on the serum concentrations of isoniazid and metabolites in tuberculosis patients [J].

Fukino, Katsumi ;

Sasaki, Yuka ;

Hirai, Shigekazu ;

Nakamura, Takayuki ;

Hashimoto, Masayo ;

Yamagishi, Fumio ;

Ueno, Koichi .

JOURNAL OF TOXICOLOGICAL SCIENCES, 2008, 33 (02) :187-195

[29] A single nucleotide polymorphism tags variation in the arylamine N-acetyltransferase 2 phenotype in populations of European background [J].

Garcia-Closas, Montserrat ;

Hein, David W. ;

Silverman, Debra ;

Malats, Nuria ;

Yeager, Meredith ;

Jacobs, Kevin ;

Doll, Mark A. ;

Figueroa, Jonine D. ;

Baris, Dalsu ;

Schwenn, Molly ;

Kogevinas, Manolis ;

Johnson, Alison ;

Chatterjee, Nilanjan ;

Moore, Lee E. ;

Moeller, Timothy ;

Real, Francisco X. ;

Chanock, Stephen ;

Rothman, Nathaniel .

PHARMACOGENETICS AND GENOMICS, 2011, 21 (04) :231-236

[30] ISONIAZID-ASSOCIATED HEPATITIS - REPORT OF AN OUTBREAK [J].

GARIBALDI, RA ;

FEREBEE, SH ;

GREGG, MB ;

DRUSIN, RE .

AMERICAN REVIEW OF RESPIRATORY DISEASE, 1972, 106 (03) :357-+

← 1 2 3 4 5 6 7 8 9 10 →